Tags : Horizon 2020

Insights+ COVID-19 Deals (Part III): Biopharma and Govt. Institutions

The emergence of the coronavirus SARS-CoV-2 and the COVID-19 pandemic has spurred global healthcare and life sciences companies, as well as government agencies, to partner at unprecedented speed to develop vaccines, treatments, and kits. This article covers the last six months of deal data provided by Chris Dokomajilar of DealForma. During the last six months (up […]Read More